Neuralink 2026-09-08 split brief · 1건

Neuralink: 임상 · 참가 ~20–26(미검증)

Neuralink: 임상 · 참가 ~20–26(미검증) · Blindsight Breakthrough 톤 · 광범위 승인 ~2028–29 관측(미검증).